SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

ST2 Rapid Quantitative Test

ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.

The ADV Antigen Rapid Test

The ADV Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of adenovirus antigen (ADV) directly from nasal/throat/nasopharyngeal swabs. It is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute Adenovirus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay)

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay)

FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free triiodothyronine 3 (FT3) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

TSH Rapid Quantitative Test

Thyroid stimulating hormone(TSH) is a hormone secreted by adenohypophysis to promote the growth and function of the thyroid gland. The changes of TSH is noted prior to the T4 and T3 for months or years, as is of great value for the diagnosis of thyroid dysfunction and lesions.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.